343
Wang D, Wang T, Xu Z, Yu H, Feng B, Zhang J, Guo C, Yin Q, Zhang Z, Li Y (2016b) Cooperative
treatment of metastatic breast cancer using host-guest nanoplatform coloaded with docetaxel
and siRNA. Small 12:488–498. https://doi.org/10.1002/smll.201502913
Wang X, Gao Z, Zhang L, Wang H, Hu X (2018, 2018) A magnetic and pH-sensitive composite
nanoparticle for drug delivery. J Nanomater. https://doi.org/10.1155/2018/1506342
Weiss G, Yen Y, Neidhart J, Young CS, Weiss S, Ryan J (2011) Abstract 1306: a phase 1b/2a study
of CRLX101, a novel nanopharmaceutical of camptothecin, in solid tumor cancer patients who
have failed standard therapy. Cancer Res 71:1306–1306. https://doi.org/10.1158/1538-7445.
am2011-1306
Xia HB, Yi J, Foo PS, Liu B (2007) Facile fabrication of water-soluble magnetic nanoparticles and
their spherical aggregates. Chem Mater 19:4087–4091. https://doi.org/10.1021/cm070918q
Xu Z, Liu S, Liu H, Yang C, Kang Y, Wang M (2015) Unimolecular micelles of amphiphilic
cyclodextrin-core star-like block copolymers for anticancer drug delivery. Chem Commun
51:15768–15777. https://doi.org/10.1039/c5cc02743h
Ye Z, Zhang Q, Wang S, Bharate P, Varela-Aramburu S, Lu M, Seeberger PH, Yin J (2016) Tumortargeted drug delivery with mannose-functionalized nanoparticles self-assembled from amphiphilic β-cyclodextrins. Chem Eur J 22:15216–15221. https://doi.org/10.1002/chem.201603294
Yuan Z, Ye Y, Gao F, Yuan HH, Lan M, Lou K, Wang W (2013) Chitosan-graft-β-cyclodextrin
nanoparticles as a carrier for controlled drug release. Int J Pharm 446:191–198. https://doi.
org/10.1016/j.ijpharm.2013.02.024
Zafar N, Fessi H, Elaissari A (2013) Cyclodextrin containing biodegradable particles: from
preparation to drug delivery applications. Int J Pharm 461:351–366. https://doi.org/10.1016/j.
ijpharm.2013.12.004
Zhai Z, Zhang F, Chen X, Zhong J, Liu G, Tian Y, Huang Q (2017) Uptake of silver nanoparticles
by DHA-treated cancer cells examined by surface-enhanced Raman spectroscopy in a microfluidic chip. Lab Chip 17:1306–1313. https://doi.org/10.1039/c7lc00053g
Zhang J, Ma PX (2009) Polymeric core-shell assemblies mediated by host-guest interactions: versatile nanocarriers for drug delivery. Angew Chem Int Ed 48:964–968. https://doi.org/10.1002/
anie.200804135
Zhang J, Ma PX (2013) Cyclodextrin-based supramolecular systems for drug delivery: recent
progress and future perspective. Adv Drug Deliv Rev 65:1215–1233. https://doi.org/10.1016/j.
addr.2013.05.001
Zhang X, Wu Z, Gao X, Shu S, Zhang H, Wang Z, Li C (2009) Chitosan bearing pendant cyclodextrin as a carrier for controlled protein release. Carbohydr Polym 77:394–401. https://doi.
org/10.1016/j.carbpol.2009.01.018
Zhang N, Li JJ, Jiang W, Ren C, Li JJ, Xin J, Li K (2010) Effective protection and controlled
release of insulin by cationic β-cyclodextrin polymers from alginate/chitosan nanoparticles. Int
J Pharm 393:213–219. https://doi.org/10.1016/j.ijpharm.2010.04.006
Zhang X, Zheng X, Wu Z, Gao X, Shu S, Wang Z, Li C (2011) β-Cyclodextrin grafting hyperbranched polyglycerols as carriers for nasal insulin delivery. Carbohydr Polym 84:1419–1425.
https://doi.org/10.1016/j.carbpol.2011.01.057
Zokaei E, Badoei-dalfrad A, Ansari M (2019) Therapeutic potential of DNAzyme loaded on chitosan/cyclodextrin nanoparticle to recovery of chemosensitivity in the MCF-7 cell line. Appl
Biochem Biotechnol 187:708. https://doi.org/10.1007/s12010-018-2836-x
Zuckerman JE, Gritli I, Tolcher A, Heidel JD, Lim D, Morgan R, Chmielowski B, Ribas A, Davis
ME, Yen Y (2014) Correlating animal and human phase Ia/Ib clinical data with CALAA-01,
a targeted, polymer-based nanoparticle containing siRNA. Proc Natl Acad Sci U S A
111:11449–11454. https://doi.org/10.1073/pnas.1411393111
7 Role of Cyclodextrins in Nanoparticle-Based Systems for Drug Delivery
Wang D, Wang T, Xu Z, Yu H, Feng B, Zhang J, Guo C, Yin Q, Zhang Z, Li Y (2016b) Cooperative
treatment of metastatic breast cancer using host-guest nanoplatform coloaded with docetaxel
and siRNA. Small 12:488–498. https://doi.org/10.1002/smll.201502913
Wang X, Gao Z, Zhang L, Wang H, Hu X (2018, 2018) A magnetic and pH-sensitive composite
nanoparticle for drug delivery. J Nanomater. https://doi.org/10.1155/2018/1506342
Weiss G, Yen Y, Neidhart J, Young CS, Weiss S, Ryan J (2011) Abstract 1306: a phase 1b/2a study
of CRLX101, a novel nanopharmaceutical of camptothecin, in solid tumor cancer patients who
have failed standard therapy. Cancer Res 71:1306–1306. https://doi.org/10.1158/1538-7445.
am2011-1306
Xia HB, Yi J, Foo PS, Liu B (2007) Facile fabrication of water-soluble magnetic nanoparticles and
their spherical aggregates. Chem Mater 19:4087–4091. https://doi.org/10.1021/cm070918q
Xu Z, Liu S, Liu H, Yang C, Kang Y, Wang M (2015) Unimolecular micelles of amphiphilic
cyclodextrin-core star-like block copolymers for anticancer drug delivery. Chem Commun
51:15768–15777. https://doi.org/10.1039/c5cc02743h
Ye Z, Zhang Q, Wang S, Bharate P, Varela-Aramburu S, Lu M, Seeberger PH, Yin J (2016) Tumortargeted drug delivery with mannose-functionalized nanoparticles self-assembled from amphiphilic β-cyclodextrins. Chem Eur J 22:15216–15221. https://doi.org/10.1002/chem.201603294
Yuan Z, Ye Y, Gao F, Yuan HH, Lan M, Lou K, Wang W (2013) Chitosan-graft-β-cyclodextrin
nanoparticles as a carrier for controlled drug release. Int J Pharm 446:191–198. https://doi.
org/10.1016/j.ijpharm.2013.02.024
Zafar N, Fessi H, Elaissari A (2013) Cyclodextrin containing biodegradable particles: from
preparation to drug delivery applications. Int J Pharm 461:351–366. https://doi.org/10.1016/j.
ijpharm.2013.12.004
Zhai Z, Zhang F, Chen X, Zhong J, Liu G, Tian Y, Huang Q (2017) Uptake of silver nanoparticles
by DHA-treated cancer cells examined by surface-enhanced Raman spectroscopy in a microfluidic chip. Lab Chip 17:1306–1313. https://doi.org/10.1039/c7lc00053g
Zhang J, Ma PX (2009) Polymeric core-shell assemblies mediated by host-guest interactions: versatile nanocarriers for drug delivery. Angew Chem Int Ed 48:964–968. https://doi.org/10.1002/
anie.200804135
Zhang J, Ma PX (2013) Cyclodextrin-based supramolecular systems for drug delivery: recent
progress and future perspective. Adv Drug Deliv Rev 65:1215–1233. https://doi.org/10.1016/j.
addr.2013.05.001
Zhang X, Wu Z, Gao X, Shu S, Zhang H, Wang Z, Li C (2009) Chitosan bearing pendant cyclodextrin as a carrier for controlled protein release. Carbohydr Polym 77:394–401. https://doi.
org/10.1016/j.carbpol.2009.01.018
Zhang N, Li JJ, Jiang W, Ren C, Li JJ, Xin J, Li K (2010) Effective protection and controlled
release of insulin by cationic β-cyclodextrin polymers from alginate/chitosan nanoparticles. Int
J Pharm 393:213–219. https://doi.org/10.1016/j.ijpharm.2010.04.006
Zhang X, Zheng X, Wu Z, Gao X, Shu S, Wang Z, Li C (2011) β-Cyclodextrin grafting hyperbranched polyglycerols as carriers for nasal insulin delivery. Carbohydr Polym 84:1419–1425.
https://doi.org/10.1016/j.carbpol.2011.01.057
Zokaei E, Badoei-dalfrad A, Ansari M (2019) Therapeutic potential of DNAzyme loaded on chitosan/cyclodextrin nanoparticle to recovery of chemosensitivity in the MCF-7 cell line. Appl
Biochem Biotechnol 187:708. https://doi.org/10.1007/s12010-018-2836-x
Zuckerman JE, Gritli I, Tolcher A, Heidel JD, Lim D, Morgan R, Chmielowski B, Ribas A, Davis
ME, Yen Y (2014) Correlating animal and human phase Ia/Ib clinical data with CALAA-01,
a targeted, polymer-based nanoparticle containing siRNA. Proc Natl Acad Sci U S A
111:11449–11454. https://doi.org/10.1073/pnas.1411393111
7 Role of Cyclodextrins in Nanoparticle-Based Systems for Drug Delivery